|
A Companion Diagnostic for Prognosis of Kidney Cancer
|
N43CO100135-000
|
$199,597
|
$199,597
|
Gillespie, John
|
20/20 GENE SYSTEMS, INC.
|
|
PredicTOR: predicting patient response to mTOR pathway inhibitors prior to treatm
|
2R44CA123994-04
|
$750,000
|
$247,500
|
Lebowitz, Michael
|
20/20 GENESYSTEMS, INC.
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP
|
2U10CA014958-36
|
$127,404
|
$11,466
|
SPARANO, JOSEPH
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Radiation Therapy Oncology Group
|
3U10CA021661-34S2
|
$1,198,505
|
$11,985
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group
|
5U10CA021661-34
|
$12,451,705
|
$124,517
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
American College of Radiology Imaging Network
|
5U01CA080098-12
|
$9,041,302
|
$452,065
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-21
|
$461,201
|
$4,612
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Eastern Cooperative Oncology Group
|
2U10CA080775-12
|
$104,956
|
$9,446
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
DF/HCC Kidney Cancer SPORE
|
5P50CA101942-07
|
$2,300,000
|
$2,300,000
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Mechanism of Acquired Resistance to VEGF-R Antagonists in RCC
|
1K08CA138900-01A1
|
$169,560
|
$169,560
|
BHATT, RUPAL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting the PI3-Kinase/Akt Pathway for the Therapy of Renal Cell Carcinoma
|
5K08CA142890-02
|
$169,400
|
$169,400
|
Cho, Daniel
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The pVHL/Jade-1/beta-catenin axis in renal cancer
|
2R01CA079830-09A1
|
$330,099
|
$330,099
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
|
Cancer and Leukemia Group B
|
3U10CA031946-29S3
|
$8,129,333
|
$81,293
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
7U10CA031946-29
|
$11,034,745
|
$110,347
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Computerized Monitoring Tool for MR-Guided Cryoablation
|
1R01CA152282-01
|
$624,903
|
$624,903
|
Tuncali, Kemal
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
To establish the BC Cancer Agency - Vancouver Centre as a major SWOG centre
|
1U10CA142559-01
|
$188,304
|
$1,883
|
BLANKE, CHARLES
|
BRITISH COLUMBIA CANCER AGENCY
|
|
Development and Validation of a FISH-Based Renal Cancer Detection Assay
|
4R44CA134103-02
|
$275,195
|
$275,195
|
HOULDSWORTH, JANE
|
CANCER GENETICS, INC.
|
|
Carle Cancer Center Community Clinical Oncology Program
|
5U10CA035195-27
|
$821,099
|
$16,422
|
ROWLAND, KENDRITH
|
CARLE FOUNDATION
|
|
Eastern Cooperative Oncology Group Studies
|
2U10CA014548-36
|
$420,754
|
$37,868
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-21S1
|
$100,000
|
$3,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-21S2
|
$72,416
|
$2,172
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-21S3
|
$100,000
|
$3,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-21S4
|
$50,000
|
$1,500
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-21
|
$5,104,400
|
$153,132
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cedar Rapids Oncology Project
|
5U10CA052352-21
|
$209,928
|
$4,199
|
WIESENFELD, MARTIN
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
Heat Shock Protein Vaccine Targeting Carbonic Anhydrase IX in Renal Cell Carcinom
|
5K23CA120075-05
|
$147,948
|
$147,948
|
KIM, HYUNG
|
CEDARS-SINAI MEDICAL CENTER
|
|
Expression profiling of renal cell carcinoma utilizing tissue from CALGB 90206
|
5R01CA133072-04
|
$429,934
|
$429,934
|
KIM, HYUNG
|
CEDARS-SINAI MEDICAL CENTER
|
|
Pathophysiology of Post-Transplantation Cancer
|
5R01CA131145-02
|
$383,116
|
$383,116
|
Pal, Soumitro
|
CHILDREN'S HOSPITAL BOSTON
|
|
Genetics of pediatric rhabdoid tumors
|
5R01CA046274-19
|
$266,860
|
$90,732
|
BIEGEL, JACLYN
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-24
|
$1,202,700
|
$24,054
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
City of Hope Southwest Oncology Group Clinical Trials
|
2U10CA046368-23
|
$431,902
|
$4,319
|
MORTIMER, JOANNE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Sunitinib Modulation of Cancer Immunotherapy
|
1R01CA150959-01
|
$268,456
|
$268,456
|
FINKE, JAMES
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Tumor Induced Dysregulation of T Cell Immunity
|
5R01CA116255-05
|
$261,383
|
$261,383
|
FINKE, JAMES
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
CCOP: Colorado Cancer Research Program
|
5U10CA067753-15
|
$959,745
|
$19,195
|
Pajon, Eduardo
|
COLORADO CANCER RESEARCH PROGRAM, INC.
|
|
Columbus Community Clinical Oncology Program (Columbus CCOP)
|
2U10CA035261-27
|
$750,000
|
$15,000
|
KUEBLER, J
|
COLUMBUS COMMUNITY CLINICAL ONCOLOGY PRG
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S1
|
$124,531
|
$1,245
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S2
|
$100,000
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S3
|
$100,000
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S4
|
$46,458
|
$465
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-46
|
$11,641,774
|
$116,418
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer and Leukemia Group B
|
5U10CA032291-29
|
$511,085
|
$5,111
|
Burstein, Harold
|
DANA-FARBER CANCER INSTITUTE
|
|
ECOG Statistical Office
|
2U10CA023318-34
|
$2,382,969
|
$214,467
|
GRAY, ROBERT
|
DANA-FARBER CANCER INSTITUTE
|
|
Functional Analysis of the Von Hippel-Lindau Protein
|
5R01CA068490-15
|
$297,903
|
$297,903
|
KAELIN, WILLIAM
|
DANA-FARBER CANCER INSTITUTE
|
|
Immunotherapy for Renal Cell Carcinoma
|
5R01CA095648-06
|
$406,901
|
$406,901
|
ERNSTOFF, MARC
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-32S1
|
$100,000
|
$3,000
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-32S2
|
$87,459
|
$2,624
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-32S3
|
$100,000
|
$3,000
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
5P30CA023108-32
|
$3,290,263
|
$98,708
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
CENTRAL ILLINOIS COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA045807-25
|
$1,350,000
|
$27,000
|
WADE, JAMES
|
DECATUR MEMORIAL HOSPITAL
|
|
Eastern Cooperative Group Chair's Office
|
2U10CA086802-12
|
$648,867
|
$58,398
|
COMIS, ROBERT
|
DREXEL UNIVERSITY
|
Total relevant funding to Kidney Cancer for this search: $44,578,835
|